Latest filing published 25 Feb 2026 for Vera Therapeutics, Inc., €56k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Laurence Matthew Skelton: trading record in brief
Laurence Matthew Skelton is a declared insider of Vera Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 4 February 2026 to 23 February 2026, the count stands at 2 filings.
The open-market record consists of 1 sale worth €56k, with no purchase. Outside the open market, there are 1 share grant.
On 25 February 2026 came the latest disclosure, an open-market sale for €56k in Vera Therapeutics, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Laurence Matthew Skelton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,582 shares@ US$41.9839Class A Common StockSEC:0002108080-26-000004:0
- 20,000 shares0Class A Common StockSEC:0002108080-26-000002:0
2 of 2 declarations
